INS and neoplasm: In another study, a mitoxantrone-insulin conjugate was synthesized and characterized, in which the in vitro stability, in vivo biodistribution, tumor-targeting properties, and pharmacokinetics were studied in mice bearing H22 hepatocarcinoma.